Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Keck

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Hypertension Reports|May 23, 2019
Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future DirectionsMathilde Keck, Reda Hmazzou, Catherine Llorens-Cortes
American Journal of Physiology. Renal Physiology|March 27, 2015
ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3Olga Andrini, Mathilde Keck, Rodolfo Briones, et al.
Marine Drugs|December 22, 2023
Acute Effects of Brevetoxin-3 Administered via Oral Gavage to MicePeggy Barbe, Jordi Molgó, Robert Thai, et al.
Journal of Molecular and Cellular Cardiology|January 2, 2019
Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in miceSolène Emmanuelle Boitard, Yannick Marc, Mathilde Keck, et al.
Frontiers in Pharmacology|August 16, 2021
LIT01-196, a Metabolically Stable Apelin-17 Analog, Normalizes Blood Pressure in Hypertensive DOCA-Salt Rats <i>via</i> a NO Synthase-dependent MechanismAdrien Flahault, Mathilde Keck, Pierre-Emmanuel Girault-Sotias, et al.
Hypertension (Dallas, Tex. : 1979)|May 9, 2019
NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating HypertensionMathilde Keck, Hugo De Almeida, Delphine Compère, et al.
Human Mutation|December 6, 2019
Analysis of CLCNKB mutations at dimer-interface, calcium-binding site, and pore reveals a variety of functional alterations in ClC-Kb channel leading to Bartter syndromeYohan Bignon, Imene Sakhi, Sara Bitam, et al.
Human Mutation|February 10, 2011
Heterogeneity in the processing of CLCN5 mutants related to Dent diseaseTeddy Grand, Sébastien L'Hoste, David Mordasini, et al.
Scientific Reports|April 17, 2019
Cardiac inflammatory CD11b/c cells exert a protective role in hypertrophied cardiomyocyte by promoting TNFR<sub>2</sub>- and Orai3- dependent signalingMathilde Keck, Mathilde Flamant, Nathalie Mougenot, et al.
Biochimica Et Biophysica Acta|June 25, 2013
Characterization of the mouse ClC-K1/Barttin chloride channelSébastien L'Hoste, Alexei Diakov, Olga Andrini, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Hypertension Reports|May 23, 2019
Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future DirectionsMathilde Keck, Reda Hmazzou, Catherine Llorens-Cortes
American Journal of Physiology. Renal Physiology|March 27, 2015
ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3Olga Andrini, Mathilde Keck, Rodolfo Briones, et al.
Marine Drugs|December 22, 2023
Acute Effects of Brevetoxin-3 Administered via Oral Gavage to MicePeggy Barbe, Jordi Molgó, Robert Thai, et al.
Journal of Molecular and Cellular Cardiology|January 2, 2019
Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in miceSolène Emmanuelle Boitard, Yannick Marc, Mathilde Keck, et al.
Frontiers in Pharmacology|August 16, 2021
LIT01-196, a Metabolically Stable Apelin-17 Analog, Normalizes Blood Pressure in Hypertensive DOCA-Salt Rats <i>via</i> a NO Synthase-dependent MechanismAdrien Flahault, Mathilde Keck, Pierre-Emmanuel Girault-Sotias, et al.
Hypertension (Dallas, Tex. : 1979)|May 9, 2019
NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating HypertensionMathilde Keck, Hugo De Almeida, Delphine Compère, et al.
Human Mutation|December 6, 2019
Analysis of CLCNKB mutations at dimer-interface, calcium-binding site, and pore reveals a variety of functional alterations in ClC-Kb channel leading to Bartter syndromeYohan Bignon, Imene Sakhi, Sara Bitam, et al.
Human Mutation|February 10, 2011
Heterogeneity in the processing of CLCN5 mutants related to Dent diseaseTeddy Grand, Sébastien L'Hoste, David Mordasini, et al.
Scientific Reports|April 17, 2019
Cardiac inflammatory CD11b/c cells exert a protective role in hypertrophied cardiomyocyte by promoting TNFR<sub>2</sub>- and Orai3- dependent signalingMathilde Keck, Mathilde Flamant, Nathalie Mougenot, et al.
Biochimica Et Biophysica Acta|June 25, 2013
Characterization of the mouse ClC-K1/Barttin chloride channelSébastien L'Hoste, Alexei Diakov, Olga Andrini, et al.
Pageof 4